Trials / Completed
CompletedNCT02666001
A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone
A Phase 1, Open-Label, Drug-Drug Interaction Study Between Methadone and BMS-663068; and Between Buprenorphine/Naloxone and BMS-663068
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to assess the effect of multiple doses of BMS-663068 on the exposure of methadone in subjects on a stable dose of methadone, and the exposure of buprenorphine and norbuprenorphine in subjects on a stable dose of buprenorphine and norbuprenorphine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-663068 | BMS-663068 |
| DRUG | Methadone | Methadone |
| DRUG | Buprenorphine and Norbuprenorphine | Buprenorphine and Norbuprenorphine |
Timeline
- Start date
- 2016-01-12
- Primary completion
- 2016-06-29
- Completion
- 2016-06-29
- First posted
- 2016-01-28
- Last updated
- 2017-08-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02666001. Inclusion in this directory is not an endorsement.